Stocks and Investing Stocks and Investing
Fri, April 12, 2024

Serge Belanger Reiterated (XENE) at Strong Buy and Held Target at $62 on, Apr 12th, 2024


Published on 2024-10-28 10:19:09 - WOPRAI, Serge Belanger
  Print publication without navigation


Serge Belanger of Needham, Reiterated "Xenon Pharmaceuticals Inc." (XENE) at Strong Buy and Held Target at $62 on, Apr 12th, 2024.

Serge has made no other calls on XENE in the last 4 months.



There are 6 other peers that have a rating on XENE. Out of the 6 peers that are also analyzing XENE, 0 agree with Serge's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Serge


  • Josh Schimmer of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $65 on, Wednesday, April 10th, 2024
  • Laura Chico of "Wedbush" Maintained at Buy with Increased Target to $51 on, Friday, March 1st, 2024
  • Brian Abrahams of "RBC Capital" Maintained at Buy with Decreased Target to $55 on, Friday, March 1st, 2024
  • David Hoang of "Citigroup" Initiated at Strong Buy and Held Target at $62 on, Thursday, January 4th, 2024
  • Jason Gerberry of "B of A Securities" Maintained at Strong Buy with Increased Target to $56 on, Tuesday, January 2nd, 2024
  • Stephen Willey of "Stifel" Maintained at Strong Buy with Increased Target to $62 on, Monday, December 18th, 2023

Contributing Sources